Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
1.59
0.03 (1.92%)
At close: Sep 29, 2025, 3:59 PM
1.65
3.77%
After-hours: Sep 29, 2025, 07:51 PM EDT
1.92% (1D)
| Bid | 1.54 |
| Market Cap | 423.14M |
| Revenue (ttm) | 29.93M |
| Net Income (ttm) | -227.78M |
| EPS (ttm) | -0.87 |
| PE Ratio (ttm) | -1.83 |
| Forward PE | -2.29 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.64 |
| Volume | 3,259,942 |
| Avg. Volume (20D) | 3,262,582 |
| Open | 1.59 |
| Previous Close | 1.56 |
| Day's Range | 1.57 - 1.63 |
| 52-Week Range | 1.10 - 5.00 |
| Beta | 1.87 |
| Ex-Dividend Date | n/a |
About AUTL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AUTL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AUTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAutolus Therapeutics is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-12.96%
Autolus Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
2 months ago
+0.83%
Autolus Therapeutics shares are trading higher after the company announced that AUCATYZL has been granted a European marketing authorization.
